1. Nasri H, Baradaran A, Ardalan MR, Mardani S, Momeni A,
Rafieian-Kopaei M: Bright renoprotective properties of metformin:
Beyond blood glucose regulatory effects. Iran J Kidney Dis 2013;
7(6): 423-428
2. Ali DK, Oriowo M, Tovmasyan A, Batinic-Haberle I, Benov L:
Late administration of Mn porphyrin-based SOD mimic enhances
diabetic complications. Redox Biol 2013; 1(1): 457-466
3. Konior A, Schramm A, Czesnikiewicz-Guzik M, Guzik TJ: NADPH
Oxidases in Vascular Pathology. Antioxid Redox Signal 2013 Nov
1. (Epub ahead of print)4. Gradinaru D, Borsa C, Ionescu C, Margina D: Advanced oxidative
and glycoxidative protein damage markers in the elderly with type
2 diabetes. J Proteomics 2013; 92: 313-322
5. Mishra N, Singh N: Blood viscosity, lipid profile, and lipid
peroxidation in type-1 diabetic patients with good and poor
glycemic control. N Am J Med Sci 2013; 5(9): 562-566
6. Mihailidou C, Papavassiliou AG, Kiaris H: A crosstalk between p21
and UPR-induced transcription factor C/EBP homologous protein
(CHOP) linked to type 2 diabetes. Biochimie 2014; 99: 19-27
7. Battacharya SK, Satyan KS, Ghosal S: Antioxidant activity of
glycowithanolides from Withania somnifera. Indian J Exp Biol
1997; 35(3): 236-239
8. Ilavarasan R, Mohideen S, Vijayalakshmi M, Manonmani G:
Hepatoprotective effect of Cassia angustifolia Vahl. Indian J Pharm
Sci 2001; 63: 504-507
9. Manonmani G, Anbarasi K, Balakrishna K, Veluchamy G, Shyamala
Devi CS: Effect of Terminalia arjuna on the antioxidant defense
system in alloxan induced diabetes in rats. Biomedicine 2002; 22:
52-61
10. Pasini AF, Garbin U, Nava MC, Stranieri C, Pellegrini M,
Boccioletti V, Luchetta ML, Fabrizzi P, Lo Cascio V, Cominacini
L: Effect of sulfhydryl and non-sulfhydryl angiotensin-converting
enzyme inhibitors on endothelial function in essential hypertensive
patients. Am J Hypertens 2007; 20(4): 443-450
11. Balazs M, Halmos T: Electron microscopic study of liver fibrosis
associated with diabetes mellitus. Exp Pathol 1985; 27: 153-162
12. Tolman, KG, Fonseca V, Tan MH, Dalpiaz A: Narrative review:
Hepatobiliary disease in type 2 diyabetes mellitus. Ann Intern Med
2004; 141: 946-956
13. Kume E, Fujimura H, Matsuki N, Ito M, Aruga C, Toriumi
W, Kitamura K, Doi K: Hepatic changes in the acute phase of
streptozotocin (SZ)-induced diabetes in mice. Exp Toxicol Pathol
2004; 55(6): 467-480
14. Lenk SE, Bhat D, Blakeney W, Dunn WA Jr: Effects of
streptozotocin-induced diabetes on rough endoplasmic reticulum
and lysosomes of rat liver. Am J Physiol 1992; 263: E856–E862
15. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic
complications: A new perspective on an old paradigm. Diabetes
1999; 48(1): 1-9
16. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T, Ikeda H, Hiai
H, Seino Y, Yamada Y: Hyperglycemia causes oxidative stress
in pancreatic beta-cells of GK rats, a model of type 2 diabetes.
Diabetes 1999; 48: 927-932
17. Bernard C, Della Zuana O, Ktorza A: Interaction between
environment and genetic background in type 2 diabetes: Lessons
from animal models. Med Sci (Paris) 2013; 29(8-9): 791-799
18. Marchetti P, Bugliani M, Boggi U, Masini M, Marselli L: The
pancreatic beta cells in human type 2 diabetes. Adv Exp Med Biol
2012; 771: 288-30919. Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J: Antioxidant
defense system in diabetic kidney: A time course study. Life Sci
1997; 60: 667-679
20. Cunningham JJ: Micronutrients as nutriceutical intervention in
diabetes mellitus. J Am Coll Nutr 1998; 17: 7-10
21. Kedziora-Kornatowska K, Szramd S, Kornatowski T, Szadujkis-
Szadurski L, Kedziora J, Bartosz G: Effect of vitamin E and vitamin
C supplementation on antioxidative state and renal glomerular
basement membrane thickness in diabetic kidney. Nephron Exp
Nephrol 2003; 95(4): e134-143
22. Vardı N, Iraz M, Öztürk F, Uçar M, Gül M, Eşrefoğlu M, Otlu A:
Deneysel diyabetin sıçan böbreklerinde meydana getirdiği histolojik
değişiklikler üzerine melatoninin iyileştirici etkileri. İnönü Üniv
Tıp Fak Dergisi 2005; 12: 145-152
23. Traisma HS, Greenwood RD: A comparative clinical evaluation of a
new proprietary method for urine testing in juvenile diabetics. Clin
Pediatr (Phila) 1973; 12(6): 357-359
24. Jaouhari JT, Lazrek HB, Jana M: The hyperglycemic activity of
Zygophyllum gaetulum extracts in alloxan induced hyperglycemic
rats. J Ethnopharmacol 2000; 69(1): 17-20
25. Bora PS, Srivastava LM, Bhatt SD: Metabolic and histopathological
effects of STZ induced diabetes in rats: Effect of propranolol and
insulin. Indian J Exp Biol 1985; 23(1): 23-26
26. Junod A, Lambert AE, Atanffacher W, Renold AE: Diabetogenic
action of streptozotocin. Relationship of dose to metabolic response.
J Clin Invest 1969; 48(11): 2129-2139
27. Sakurai K, Katoh M, Someno K, Fujimoto Y: Apoptosis and
mitochondrial damage in INS-1 cells treated with alloxan. Biol
Pharm Bull 2001; 24(8): 876-882
28. Sabu MC, Smitha K, Kuttan R: Anti-diabetic activity of green
tea polyphenols and their role in reducing oxidative stress in
experimental diabetes. J Ethnopharmacol 2002; 83(1-2): 109-116
29. Roy S, Sehgal R, Padhy BM, Kumar VL: Antioxidant and protective
effect of latex of Calotropis procera against alloxan-induced
diabetes in rats. J Ethnopharmacol 2005; 102(3): 470-473
30. Sepici-Dincel A, Açıkgöz Ş, Çevik C, Sengelen M, Yeşilada E:
Effects of in vivo antioxidant enzyme activities of myrtle oil in
normoglycaemic and alloxan diabetic rabbits. J Ethnopharmacol
2007; 110(3): 498-503
31. Makri OE, Ferlemi AV, Lamari FN, Georgakopoulos CD: Saffron
administration prevents selenite-induced cataractogenesis. Mol Vis
2013; 19: 1188-119732. Maldonado PD, Alvarez-Idaboy JR, Aguilar-González A, Lira-
Rocha A, Jung-Cook H, Medina-Campos ON, Pedraza-Chaverrí J,
Galano A: Role of allyl group in the hydroxyl and peroxyl radical
scavenging activity of S-allylcysteine. J Phys Chem B 2011;
115(45): 13408-13417
33. Mak IT, Freedman AM, Dickens BF, Weglicki WB: Protective
effects of sulfhydryl-containing angiotensin-converting enzyme
inhibitors against free radical injury in endothelial cells. Biochem
Pharmacol 1990; 40: 2169-2175
34. Cominacini L, Pasini A, Garbin U, Evangelista S, Crea AE,
Tagliacozzi D, Nava C, Davoli A, LoCascio V: Zofenopril inhibits
the expression of the adhesion molecules on endothelial cells by
reducing reactive oxygen species. Am J Hypertens 2002; 15: 891-
895
35. Brůha R, Dvořák K, Petrtýl J: Liver disorders in diabetic patients.
Vnitr Lek 2013; 59(7): 546-550
36. Latry P, Bioulac-Sage P, Echinard E, Gin H, Boussarie L, Grimaud
JA, Balabaud C: Perisinusoidal fibrosis and basement membranelike
material in the livers of diabetic patients. Hum Pathol 1987; 18:
775-780
37. Gruden G, Perin PC, Camussi G: Insight on the pathogenesis of
diabetic nephropathy from the study of podocyte and mesangial cell
biology. Curr Diabetes Rev 2005; 1(1): 27-40
38. Fioretto P, Bruseghin M, Barzon I, Arboit M, Vestra MD: Diabetic
nephropathy: An update on renal structure. Int Congr Ser 2007;
1303: 51-59
39. Yousef WM, Morsey MD, Waheed MMA, Ghanayeem NM, Omar
AH: Effect of some calcium channel blockers in experimentally
induced diabetic nephropathy in rats. IJPT 2004; 3: 45-56
40. Geoffroy K, Troncy L, Wiernsperger N, Lagarde M, El Bawab S:
Glomerular proliferation during early stages of diabetic nephropathy
is associated with local increase of sphingosine-1-phosphate levels.
FEBS Lett 2005; 579: 1249-1254
41. Karabay G, Erdoğan D, Take G, Karasu Ç: Deneysel diyabette
probukol uygulanmasının endokrin pancreas dokusuna etkisinin
ultrastrüktürel olarak incelenmesi. Uludağ Üniv Tıp Fak Dergisi
2005; 31: 5-8
42. Chatenoud L, You S, Okada H, Kuhn C, Michaud B, Bach JF:
99th Dahlem conference on infection, inflammation and chronic
inflammatory disorders: Immune therapies of type 1 diabetes: New
opportunities based on the hygiene hypothesis. Clin Exp Immunol
2010; 160(1): 106-112
Thank you for copying data from http://www.arastirmax.com
